Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study
- PMID: 17166316
- DOI: 10.1017/S1355617707070208
Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study
Abstract
The current study characterizes cognitive and psychiatric status in hematopoietic stem cell transplantation (HSCT) patients shortly before and after transplant. Thirty adult patients were assessed prospectively 1-2 weeks before transplantation and 100 days posttransplantation on neuropsychological and psychiatric measures. Before transplant, participants showed mild impairments on several neuropsychological measures, with the poorest performances occurring on learning and attention. Psychiatric functioning was significantly elevated compared with normative data. Significant improvements, however, were observed on neuropsychological measures by 100 days after transplant. Depression and anxiety scores also improved. Candidates for HSCT experienced mild diffuse cognitive dysfunction and psychiatric morbidity before the procedure, but these symptoms significantly improved by 3 months following their transplant in this small sample. Education about these possible pretransplant sequelae and the potential for rebound may be helpful to patients and families as they prepare for this treatment and the recovery period.
Similar articles
-
Changes in cognitive functioning in the year after hematopoietic stem cell transplantation.Cancer. 2007 Oct 1;110(7):1560-7. doi: 10.1002/cncr.22962. Cancer. 2007. PMID: 17685391
-
Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.Arch Clin Neuropsychol. 2009 Nov;24(7):689-98. doi: 10.1093/arclin/acp060. Epub 2009 Sep 18. Arch Clin Neuropsychol. 2009. PMID: 19767298
-
Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation.Psychooncology. 2008 May;17(5):480-7. doi: 10.1002/pon.1261. Psychooncology. 2008. PMID: 17879971
-
A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.J Affect Disord. 2008 Feb;106(1-2):1-27. doi: 10.1016/j.jad.2007.06.006. Epub 2007 Aug 20. J Affect Disord. 2008. PMID: 17707915 Review.
-
[Depressive disorders in leukemia].Psychiatr Pol. 2003 Sep-Oct;37(5):799-809. Psychiatr Pol. 2003. PMID: 14631600 Review. Polish.
Cited by
-
Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.Cancer. 2012 Jul 1;118(13):3407-16. doi: 10.1002/cncr.26645. Epub 2011 Dec 2. Cancer. 2012. PMID: 22139882 Free PMC article.
-
Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantation.Contemp Clin Trials. 2020 Aug;95:106076. doi: 10.1016/j.cct.2020.106076. Epub 2020 Jun 30. Contemp Clin Trials. 2020. PMID: 32619524 Free PMC article. Clinical Trial.
-
Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.J Clin Oncol. 2020 Apr 20;38(12):1312-1321. doi: 10.1200/JCO.19.01085. Epub 2020 Feb 21. J Clin Oncol. 2020. PMID: 32083992 Free PMC article.
-
Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.PLoS One. 2011 Apr 29;6(4):e19246. doi: 10.1371/journal.pone.0019246. PLoS One. 2011. PMID: 21559428 Free PMC article.
-
Short-Term Impact of Hematopoietic Stem Cell Transplantation on Depressive Behavior, Cognition and Quality of Life in Leukemia Patients.Indian J Hematol Blood Transfus. 2024 Jan;40(1):83-90. doi: 10.1007/s12288-023-01653-2. Epub 2023 Apr 4. Indian J Hematol Blood Transfus. 2024. PMID: 38312172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical